The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is a primary partnership of Georgetown University (GU) and Howard University (HU), with 3 affiliated hospital systems and research institutes: MedStar Health and Research Institute (MHRI), Oak Ridge National Laboratory (ORNL), and the Washington, DC Veteran's Affairs Medical Center (DCVAMC).
The specific aims of GHUCCTS are: 1) to improve the infrastructure that supports high quality interdisciplinary clinical and translational research, both via inter-institutional collaborations between all GHUCCTS institutions as well as multicenter clinical trials across the national CTSA consortium, with increasing levels of speed and efficiency, and to develop innovative computational methods to speed and enhance translation; 2) to continue to develop GHUCCTS as a model of inter-institutional collaboration that leverages the strengths and attributes of its diverse participating institutions to evolve GHUCCTS into regional CTSA hub with unique and synergistic strengths; 3) to leverage our location, expertise and the co-leadership of a minority-serving institution to design and implement research that will have a high impact on underserved populations with health disparities, including minorities, people with disabilities, and elderly populations; 4) to design and disseminate vibrant and innovative educational programs at multiple levels (undergraduate, medical school, graduate, study coordinators, research nurses, and junior faculty) that promote team science and provides the highest quality of career development training for the clinical and translational investigators of the future; and 5) to both draw from and contribute to the collective efforts of the national CTSA consortium to advance each of the Strategic Goals of GHUCCTS, the National Center for Advancing Translational Science (NCATS), and the CTSA national consortium. The integration of multiple clinical and translational resources across the diverse GHUCCTS institutions will be accompanied by a strong research education, training, and career development program that will train a new generation of clinical and translational researchers. Our innovative approaches to collaboration and interdisciplinary research involving multiple major research-intensive institutions of our region, in collaboration with the national CTSA network, will ensure that our institutions and our community in the Washington, DC area benefit maximally from the generation and application of new discoveries in clinical and translational science.

Public Health Relevance

The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is a partnership of Georgetown University, Howard University, MedStar Health Research Institute, the Washington DC Veterans Administration Medical Center, and Oak Ridge National Laboratory. Through an innovative collaboration among multiple major research-intensive institutions of our region, GHUCCTS will transform and advance the research and training enterprise in the greater Washington DC region, and will accelerate the translation of scientific discoveries into improved patient care and public health to ensure that our communities in the Washington, DC area benefit maximally from the generation and application of new discoveries in clinical and translational science.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
5UL1TR001409-02
Application #
9134229
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Brazhnik, Olga
Project Start
2015-08-28
Project End
2020-03-31
Budget Start
2016-04-01
Budget End
2017-03-31
Support Year
2
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Georgetown University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Singh, Jasbir; Reddy, Uma M; Huang, Chun-Chih et al. (2018) Racial/Ethnic Differences in Labor Induction in a Contemporary US Cohort: A Retrospective Cohort Study. Am J Perinatol 35:361-368
Aroda, Vanita R; Arulandu, Joseph R; Cannon, Anthony J (2018) Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy for the Treatment of Type 2 Diabetes: Are Two Agents Better Than One? Clin Diabetes 36:138-147
Lam, Phillip H; Dooley, Daniel J; Fonarow, Gregg C et al. (2018) Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial. Eur J Heart Fail 20:359-369
Kiechle, Eric S; McKenna, Colleen M; Carter, Hannah et al. (2018) Medication Allergy and Adverse Drug Reaction Documentation Discrepancies in an Urban, Academic Emergency Department. J Med Toxicol 14:272-277
Jonklaas, Jacqueline; Tefera, Eshetu; Shara, Nawar (2018) Prescribing Therapy for Hypothyroidism: Influence of Physician Characteristics. Thyroid :
Smith, Kelly M; Baker, Kelley M; Bardsley, Joan K et al. (2018) Redesigning Hospital Diabetes Education: A Qualitative Evaluation With Nursing Teams. J Nurs Care Qual :
Jonklaas, Jacqueline; Tefera, Eshetu; Shara, Nawar (2018) Physician Choice of Hypothyroidism Therapy: Influence of Patient Characteristics. Thyroid 28:1416-1424
Jones, Derek; Banerjee, Anirban; Berger, Peter Z et al. (2018) Inherent differences in keratinocyte function in hidradenitis suppurativa: Evidence for the role of IL-22 in disease pathogenesis. Immunol Invest 47:57-70
Ryu, Rachel J; Easterling, Thomas R; Caritis, Steve N et al. (2018) Prednisone Pharmacokinetics During Pregnancy and Lactation. J Clin Pharmacol 58:1223-1232
Choi, Yongwook; Banerjee, Anirban; McNish, Sean et al. (2018) Co-occurrence of Anaerobes in Human Chronic Wounds. Microb Ecol :

Showing the most recent 10 out of 288 publications